Jai Radhe Sales Megluin Antimonnate Jai Radhe Sales Megluin Antimonnate

X

Find Meglumine Antimonate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)
24
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Meglumine Antimonate
Also known as: Meglumine antimonate, Meglumine antimoniate, N-methylglucamine antimonate, 133-51-7, Methylglucamine antimonate, Protostib
Molecular Formula
C7H18NO8Sb
Molecular Weight
365.98  g/mol
InChI Key
XOGYVDXPYVPAAQ-SESJOKTNSA-M
FDA UNII
75G4TW236W

ANTIMONY salt of meglumine that is used in the treatment of LEISHMANIASIS.
1 2D Structure

Meglumine Antimonate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
hydroxy(dioxo)-5-stibane;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
2.1.2 InChI
InChI=1S/C7H17NO5.H2O.2O.Sb/c1-8-2-4(10)6(12)7(13)5(11)3-9;;;;/h4-13H,2-3H2,1H3;1H2;;;/q;;;;+1/p-1/t4-,5+,6+,7+;;;;/m0..../s1
2.1.3 InChI Key
XOGYVDXPYVPAAQ-SESJOKTNSA-M
2.1.4 Canonical SMILES
CNCC(C(C(C(CO)O)O)O)O.O[Sb](=O)=O
2.1.5 Isomeric SMILES
CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.O[Sb](=O)=O
2.2 Other Identifiers
2.2.1 UNII
75G4TW236W
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Meglumine Antimoniate

2. N Methylglucamine Antimonate

3. N-methylglucamine Antimonate

2.3.2 Depositor-Supplied Synonyms

1. Meglumine Antimonate

2. Meglumine Antimoniate

3. N-methylglucamine Antimonate

4. 133-51-7

5. Methylglucamine Antimonate

6. Protostib

7. 75g4tw236w

8. N-methyl Glucamine Antimoniate

9. 2168-rp

10. Einecs 205-108-3

11. Glucantim

12. Unii-75g4tw236w

13. 1-deoxy-1-(methylamino)glucitol Antimonate(v)

14. 1-deoxy-1-(methylamino)-d-glucitol, Compound With Antimonic Acid (1:1)

15. D-glucitol, 1-deoxy-1-(methylamino)-, Compd. With Antimonic Acid (1:1)

16. Glucitol, 1-deoxy-1-(methylamino)-, Compd. With Antimonic Acid (1:1), D-

17. Schembl146372

18. Dtxsid4043935

19. D-glucitol, 1-deoxy-1-(methylamino)-, Trioxoantimonate(1-)

20. Mfcd01725422

21. Meglumine Antimonate [who-dd]

22. Akos025310684

23. Db13732

24. N-methylglucamine Antimonate [mi]

25. 133m517

26. Q2757969

27. (2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentaol Stibenate

28. D-glucitol, 1-deoxy-1-(methylamino)-, Compd. With Antimonic Acid (hsbo3) (1:1)

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 365.98 g/mol
Molecular Formula C7H18NO8Sb
Hydrogen Bond Donor Count7
Hydrogen Bond Acceptor Count9
Rotatable Bond Count6
Exact Mass365.00705 g/mol
Monoisotopic Mass365.00705 g/mol
Topological Polar Surface Area168 Ų
Heavy Atom Count17
Formal Charge0
Complexity180
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antiprotozoal Agents

Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)


4.2 ATC Code

P - Antiparasitic products, insecticides and repellents

P01 - Antiprotozoals

P01C - Agents against leishmaniasis and trypanosomiasis

P01CB - Antimony compounds

P01CB01 - Meglumine antimonate


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY